디지털 당뇨병 관리 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Digital Diabetes Management Market size is expected to reach USD 101.62 Billion in 2034 from USD 31.18 Billion (2025) growing at a CAGR of 14.03% during 2026-2034.

The global digital diabetes management market has expanded rapidly with the growth of digital health technologies. Rising diabetes cases worldwide have increased the need for continuous monitoring and management tools. Mobile apps, wearable devices, and connected glucose monitors have improved patient engagement and treatment outcomes.

Major drivers include the increasing use of smartphones and wearable health devices. Telemedicine services and remote patient monitoring systems have gained popularity, especially after the pandemic. Growing awareness about self-care and preventive healthcare supports market growth. Healthcare providers are also adopting digital platforms to track patient data more effectively.

Looking ahead, the market is expected to grow strongly with advancements in artificial intelligence and data analytics. Integration of digital tools with healthcare systems will improve personalized treatment plans. However, data privacy concerns and high device costs may limit adoption in some regions. Overall, digital transformation in healthcare will support long-term growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product & Service

• Devices (Smart Glucose Meters, Continuous Glucose Monitoring (Cgm) Systems, Smart Insulin Pens, Smart Insulin Pumps/Closed-Loop Pumps & Smart Insulin Patches)
• Application (Diabetes & Blood Glucose Tracking Apps, Obesity & Diet Management Apps)
• Data Management Software & Platforms
• Services

By Device Type

• Handheld Devices
• Wearable Devices

By End User

• Self/Home Healthcare
• Hospitals & Specialty Diabetes Clinics
• Academic & Research Institutes

COMPANIES PROFILED

• Medtronic, B Braun Melsungen AG, Dexcom Inc, Abbott Laboratories, F HoffmannLa Roche, Insulet Corporation, Tandem Diabetes Care, Ascensia Diabetes Care Holdings AG, LifeScan Inc, Tidepool, AgaMatrix, Glooko Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DIGITAL DIABETES MANAGEMENT MARKET: BY PRODUCT & SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product & Service
• 4.2. Devices (Smart Glucose Meters, Continuous Glucose Monitoring (Cgm) Systems, Smart Insulin Pens, Smart Insulin Pumps/Closed-Loop Pumps & Smart Insulin Patches) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Application (Diabetes & Blood Glucose Tracking Apps, Obesity & Diet Management Apps) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Data Management Software & Platforms Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DIGITAL DIABETES MANAGEMENT MARKET: BY DEVICE TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Device Type
• 5.2. Handheld Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Wearable Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DIGITAL DIABETES MANAGEMENT MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Self/Home Healthcare Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Hospitals & Specialty Diabetes Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DIGITAL DIABETES MANAGEMENT MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product & Service
  • 7.2.2 By Device Type
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product & Service
  • 7.3.2 By Device Type
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product & Service
  • 7.4.2 By Device Type
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product & Service
  • 7.5.2 By Device Type
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product & Service
  • 7.6.2 By Device Type
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL DIGITAL DIABETES MANAGEMENT INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Medtronic
  • 9.2.2 B. Braun Melsungen AG
  • 9.2.3 Dexcom Inc
  • 9.2.4 Abbott Laboratories
  • 9.2.5 F. Hoffmann-La Roche
  • 9.2.6 Insulet Corporation
  • 9.2.7 Tandem Diabetes Care
  • 9.2.8 Ascensia Diabetes Care Holdings AG
  • 9.2.9 LifeScan Inc
  • 9.2.10 Tidepool
  • 9.2.11 AgaMatrix
  • 9.2.12 Glooko Inc